MPL and Thrombocytopenia: However, larger further studies are needed to improve the clinical assessment and standardization of diagnosis of patients with ITs and to evaluate the efficacy of innovative therapeutic approaches (e.g., thrombopoietin receptor agonists) used successfully in acquired thrombocytopenias (11–13).